SEARCH

SEARCH BY CITATION

References

  • 1
    Køster A 1990 Hormone replacement therapy: Use patterns in 51-year-old Danish women. Maturitas 12:345356.
  • 2
    Munk-Jensen N, Nielsen SP, Obel EB, Eriksen PB 1988 Reversal of postmenopausal vertebral bone loss by oestrogen and progestogen: A double blind controlled study. BMJ 296:11501152.
  • 3
    Quigley TEM, Purvis LM, Burnier AM, Brooks P 1987 Estrogen therapy arrests bone loss in elderly women. Am J Obstet Gynecol 156:15161523.
  • 4
    Lindsay R 1980 Prevention of spinal osteoporosis in oophorectomised women. Lancet 2:11511154.
  • 5
    Lindsay R 1993 Consensus development conference on osteoporosis; hormone replacement and treatment for osteoporosis. Am J Med 95:1S78S.
  • 6
    Paganini-Hill A, Ross RK, Gerkins VR, Henderson BE, Arthur M, Mack TM 1981 Menopausal estrogen therapy and hip fractures. Ann Intern Med 95:2831.
  • 7
    Ettinger B, Genant HK, Cann CE 1985 Long-term estrogen replacement therapy prevents bone Loss and fractures. Ann Intern Med 102:319324.
  • 8
    Lufkin EG, Wahner HW, O'Fallon WM, Hodgson SF, Kotowicz MA, Lane AW, Judd HL, Caplan RH, Riggs BL 1992 Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med 117:19.
  • 9
    Mosekilde L, Beck-Nielsen H, Sørensen OH, Nuelsen SP, Charles P, Vestergaard P, Hermann AP, Gran J, Hansen TB, Abrahamsen B, Ebbesen EN, Stilgren L, Jensen LB, Brot C, Hansen B, Tofteng CL, Eiken P, Kolthoff W 2000 Hormonal replacement therapy reduces forearm fracture incidence in recent postmenopausal women-results of the Danish Osteoporosis Prevention Study. Maturitas 36:181193.
  • 10
    Hassager C, Christiansen C 1989 Estrogen/gestagen therapy changes soft tissue body composition in postmenopausal women. Metabolism 38:662665.
  • 11
    Panotopoulos G, Raison J, Ruiz JC, Guy Grand B, Basdevant A 1997 Weight gain at the time of menopause. Hum Reprod 12(Suppl 1):126133.
  • 12
    Nachtigall LE 1990 Enhancing patient compliance with hormone replacement therapy at menopause. Obstet Gynecol 75(Suppl 4):77S80S.
  • 13
    Ryan PJ, Harrison R, Blake GM, Fogelman I 1992 Compliance with hormone replacement therapy (HRT) after screening for post menopausal osteoporosis. Br J Obstet Gynacol 99:325328.
  • 14
    Norman RJ, Flight IH, Rees MC 2000 Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: Weight and body fat distribution. Cochrane Database Syst Rev 2:CD001018CD001018.
  • 15
    van Seumeren I 2000 Weight gain and hormone replacement therapy: Are women's fears justified? Maturitas 34(Suppl 1):S3S8.
  • 16
    Chmouliovsky L, Habicht F, James RW, Lehmann T, Campana A, Golay A 1999 Beneficial effect of hormone replacement therapy on weight loss in obese menopausal women. Maturitas 32:147153.
  • 17
    Crawford SL, Casey VA, Avis NE, McKinlay SM 2000 A longitudinal study of weight and the menopause transition: Results from the Massachusetts Women's Health Study. Menopause 7:96104.
  • 18
    Reubinoff BE, Wurtman J, Rojansky N, Adler D, Steen P, Schenker JG, Brzezinski A 1995 Effects of hormone replacement therapy on weight, body composition, fat distribution, and food intake in early postmenopausal women: A prospective study. Fertil Steril 64:963968.
  • 19
    Espeland MA, Stefanick ML, Kritz-Silverstein D, Fineberg SE, Waclawiw MA, James MK, Greendale GA 1997 Effect of postmenopausal hormone therapy on body weight and waist and hip girths. Postmenopausal Estrogen-Progestin Interventions Study Investigators. J Clin Endocrinol Metab 82:15491556.
  • 20
    Compston J, Laskey M, Croucher P, Coxon A, Kreitzman S 1992 Effect of diet-induced weight loss on total body bone mass. Clin Sci (Lond) 82:429432.
  • 21
    Jensen LB, Quaade F, Sørensen OH 1994 Bone loss accompanying voluntary weight loss in obese humans. J Bone Miner Res 9:459463.
  • 22
    Ricci TA, Chowdhury HA, Heymsfield SB, Stahl T, Pierson RN Jr, Shapses SA 1998 Calcium supplementation suppresses bone turnover during weight reduction in postmenopausal women. J Bone Miner Res 13:10451050.
  • 23
    Mosekilde L, Hermann AP, Beck-Nielsen H, Charles P, Nielsen SP, Sørensen OH 1999 The Danish Osteoporosis Prevention Study (DOPS): Project design and inclusion of 2016 normal perimenopausal women. Maturitas 31:207219.
  • 24
    Vestergaard P, Hermann AP, Gram J, Jensen LB 1997 Improving compliance with hormonal replacement therapy in primary osteoporosis prevention. Maturitas 28:137145.
  • 25
    Abrahamsen B, Gram J, Hansen TB, Beck-Nielsen H 1995 Cross-calibration of QDR-2000 and QDR-1000 dual energy X-ray densitometers for bone mineral and soft tissue measurements. Bone 16:385391.
  • 26
    Petersen JR, Drabaek H, Mehlsen J, Haedersdal C, Moller ML 1993 Systolic blood pressure at rest and during submaximal and maximal exercise on ergometer bicycle. The value of automatic and auscultatory determination. Ugeskr Laeger 155:631635.
  • 27
    Kristensen K, Pedersen SB, Vestergaard P, Mosekilde L, Richelsen B 1999 Hormone replacement therapy affects body composition and leptin differently in obese and non-obese postmenopausal women. J Endocrinol 163:5562.
  • 28
    Aloia JF, Vaswani A, Russo L, Sheehan M, Flaster E 1995 The influence of menopause and hormonal replacement therapy on body cell mass and body fat mass. Am J Obstet Gynecol 172:896900.
  • 29
    Andersen NL, Fagt S, Groth MV, Hartkopp HB, Møller A, Ovesen L, Warming DL 1995 Danskernes Kostvaner. Levnedsmiddelstyrelsen, Copenhagen, Denmark, pp. 1298.
  • 30
    Heitmann BL, Lissner L, Osler M 2000 Do we eat less fat, or just report so? Int J Obes Relat Metab Disord 24:435442.
  • 31
    Jørgensen LM, Sørensen TI, Schroll M, Larsen S 1995 Influence of dietary factors on weight change assessed by multivariate graphical models. Int J Obes Relat Metab Disord 19:909912.
  • 32
    Derby CA, Hume AL, Barbour MM, McPhillips J, Lasater TM, Carleton RA 1993 Correlates of post-menopausal estrogen use and trends through the 1980s in two south-eastern New England communities. Am J Epidemiol 137:11251135.
  • 33
    Oddens BJ, Boulet MJ, Lehert P, Visser AP 1992 Has the climacteric been medicalized? A study on the use of medication for climacteric complaints in four countries. Maturitas 15:171181.
  • 34
    MacLennan AH, MacLennan A, Wilson D 1993 The prevalence of oestrogen replacement therapy in South Australia. Maturitas 16:175183.
  • 35
    Jensen LB, Hilden J 1996 Sociological and behavioural characteristics of perimenopausal women with an express attitude to hormone substitution therapy. Maturitas 23:7383.
  • 36
    Reid IR, Legge M, Stapleton JP, Evans MC, Grey AB 1995 Regular exercise dissociates fat mass and bone density in premenopausal women. J Clin Endocrinol Metab 80:17641768.
  • 37
    Salamone LM, Glynn N, Black D, Epstein RS, Palermo L, Meilahn E, Kuller LH, Cauley JA 1995 Body composition and bone mineral density in premenopausal and early perimenopausal women. J Bone Miner Res 10:17621768.
  • 38
    Brot C, Jensen LB, Sørensen OH 1997 Bone mass and risk factors for bone loss in perimenopausal Danish women. J Intern Med 242:505511.
  • 39
    Goulding A, Taylor RW 1998 Plasma leptin values in relation to bone mass and density and to dynamic biochemical markers of bone resorption and formation in postmenopausal women. Calcif Tissue Int 63:456458.
  • 40
    Klein KO, Larmore KA, de Lancey E, Brown JM, Considene RV, Hassink SG 1998 Effect of obesity on estradiol level, and its relationship to leptin, bone maturation, and bone mineral density in children. J Clin Endocrinol Metab 83:34693475.
  • 41
    Odabasi E, Ozata M, Turan M, Bingol N, Yonem A, Cakir B, Kutlu M, Ozdemir K 2000 Plasma leptin concentrations in postmenopausal women with osteoporosis. Eur J Endocrinol 142:170173.